Research ArticleSupplement
The Future of Nuclear Medicine as an Independent Specialty
Johannes Czernin, Ida Sonni, Aria Razmaria and Jeremie Calais
Journal of Nuclear Medicine September 2019, 60 (Supplement 2) 3S-12S; DOI: https://doi.org/10.2967/jnumed.118.220558
Johannes Czernin
Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California
Ida Sonni
Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California
Aria Razmaria
Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California
Jeremie Calais
Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California
In this issue
Journal of Nuclear Medicine
Vol. 60, Issue Supplement 2
September 1, 2019
The Future of Nuclear Medicine as an Independent Specialty
Johannes Czernin, Ida Sonni, Aria Razmaria, Jeremie Calais
Journal of Nuclear Medicine Sep 2019, 60 (Supplement 2) 3S-12S; DOI: 10.2967/jnumed.118.220558
Jump to section
Related Articles
- No related articles found.
Cited By...
- Redesigned Curricula, Stringent Licensing Criteria, and Integrated Independence Are Conditions for a Bright Future for Nuclear Medicine in the United States
- The Future of Nuclear Medicine in the United States
- How Many Theranostics Centers Will We Need in the United States?
- PSMA Expression Assessed by PET Imaging Is a Required Biomarker for Selecting Patients for Any PSMA-Targeted Therapy
- Diversity, Equity, and Inclusion in Academic Nuclear Medicine: National Survey of Nuclear Medicine Residency Program Directors
- The New Integrated Nuclear Medicine and Radiology Residency Program in The Netherlands: Why Do Residents Choose to Subspecialize in Nuclear Medicine and Why Not?
- The Disappearing Act of Nuclear Medicine in The Netherlands: Just a New Trick by the Great Harry Houdini?
- Reply: Diversity, Not Divisiveness, Is the Future of Nuclear Medicine
- Diversity, Not Divisiveness, Is the Future of Nuclear Medicine
- Nuclear Medicine, Molecular Imaging, and Theranostics: The Future Is Bright
- The Standard of Care: From Nuclear Radiology to Nuclear Medicine
- Of Sheep and Wolves: Curtailing Coverage for Essential Imaging Tests Based on Flawed Use and Cost Arguments
- Future of Theranostics: An Outlook on Precision Oncology in Nuclear Medicine
- Driving the Future of Nuclear Medicine